0001935597-22-000001.txt : 20220628 0001935597-22-000001.hdr.sgml : 20220628 20220628133524 ACCESSION NUMBER: 0001935597-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220628 DATE AS OF CHANGE: 20220628 EFFECTIVENESS DATE: 20220628 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Centaurus Therapeutics, Inc. CENTRAL INDEX KEY: 0001935597 IRS NUMBER: 811296031 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-450491 FILM NUMBER: 221048767 BUSINESS ADDRESS: STREET 1: 1700 OWENS STREET, SUITE 515 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-606-8129 MAIL ADDRESS: STREET 1: 1700 OWENS STREET, SUITE 515 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 D 1 primary_doc.xml X0708 D LIVE 0001935597 Centaurus Therapeutics, Inc. 1700 OWENS STREET, SUITE 515 SAN FRANCISCO CA CALIFORNIA 94158 415-606-8129 DELAWARE None None Corporation true Stephen Halasz 1700 Owens Street, Suite 515 San Francisco CA CALIFORNIA 94158 Executive Officer Director Jeremy Blitzer 1700 Owens Street, Suite 515 San Francisco CA CALIFORNIA 94158 Executive Officer Director Other Decline to Disclose 06b false 2022-06-10 false true false 0 6999961 1999980 4999981 false 1 0 0 0 false Centaurus Therapeutics, Inc. /s/Stephen Halasz Stephen Halasz Co-Chief Executive Officer 2022-06-21